📰 Eric Marcotulli News
Eric Marcotulli News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Marcotulli. Real-time updates on events, politics, business and more.
September 8, 2023
NMN (Nicotinamide Mononucleotide) is a type of molecule that your body cells need to produce NAD (Nicotinamide Adenine Dinucleotide). NMN and NAD work together to boost your cells’ metabolic rate, reduce aging, provide energy, etc.
May 14, 2023
There are a growing number of tests that will predict your biological age. What you do with that information is key.
June 1, 2022
/PRNewswire/ -- Elysium Health, Inc.™, a leading life sciences company focused on aging research, today announced the initiation of research at Mayo Clinic to...
April 6, 2022
/PRNewswire/ -- Elysium Health, Inc.™, a leading life sciences company focused on aging research, has entered into a material transfer agreement with the...
March 23, 2022
/PRNewswire/ -- Elysium Health, Inc.™, a leading life sciences company focused on aging research, has entered into a material transfer agreement (MTA) with the...
February 15, 2022
/PRNewswire/ -- Elysium Health, Inc.,™ a leading life sciences company focused on aging research, is pleased to announce that United States District Court...
October 6, 2021
/PRNewswire/ -- Elysium Health, Inc.™, a leading life sciences company developing clinically validated health products based on advancements in aging research,...
October 1, 2021
After five years of litigation, jurors in federal district court in California delivered a split verdict in the years long legal dispute between ChromaDex and Elysium, with both sides claiming victory.
December 15, 2020
Elysium Health™ Announces Initiation of Phase II Clinical Trial at Mayo Clinic to Evaluate BASIS™ for Prevention of Acute Kidney Injury After Cardiac Surgery News provided by Share this article NEW YORK, Dec. 15, 2020 /PRNewswire/ -- Elysium Health, Inc., TM a life sciences company developing clinically validated health products based on aging research, today announced the initiation of a Phase II clinical trial at Mayo Clinic to evaluate the efficacy of BASIS TM for the prevention of ac...